chr5-75104695-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001372053.1(ANKRD31):āc.4864C>Gā(p.Leu1622Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,536,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001372053.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD31 | NM_001372053.1 | c.4864C>G | p.Leu1622Val | missense_variant | 22/26 | ENST00000506364.6 | NP_001358982.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD31 | ENST00000506364.6 | c.4864C>G | p.Leu1622Val | missense_variant | 22/26 | 5 | NM_001372053.1 | ENSP00000427262.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000106 AC: 15AN: 140988Hom.: 0 AF XY: 0.000106 AC XY: 8AN XY: 75336
GnomAD4 exome AF: 0.0000108 AC: 15AN: 1384382Hom.: 0 Cov.: 33 AF XY: 0.0000132 AC XY: 9AN XY: 683012
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.4693C>G (p.L1565V) alteration is located in exon 21 (coding exon 21) of the ANKRD31 gene. This alteration results from a C to G substitution at nucleotide position 4693, causing the leucine (L) at amino acid position 1565 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at